about
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastomaBMI1 is a therapeutic target in recurrent medulloblastomaPublisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastomaMicroglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastomaNanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcomaLocoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
P50
Q34553348-4D02AE33-2170-4E74-A0DF-9FCCC80EAFEAQ57295420-DC01E0E8-C0CE-433E-B45D-F8A26EE102E7Q57805008-A5E7D343-0A89-473D-B6BC-C075B1B83F11Q58617513-45A5D66E-C901-46F8-9DC9-AAD216AEB341Q61451761-B5FCE18D-2B73-40B5-8B67-F4CB1FDDF43BQ61816620-F1D5FF20-C21B-4627-BCAB-A204AE8C397CQ93271201-1D4DF1A9-D1A9-4FB9-B4C6-BABB62FE406E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1829-7856
@en
name
Siddhartha Mitra
@ast
Siddhartha Mitra
@en
Siddhartha Mitra
@es
Siddhartha Mitra
@nl
type
label
Siddhartha Mitra
@ast
Siddhartha Mitra
@en
Siddhartha Mitra
@es
Siddhartha Mitra
@nl
prefLabel
Siddhartha Mitra
@ast
Siddhartha Mitra
@en
Siddhartha Mitra
@es
Siddhartha Mitra
@nl
P106
P31
P496
0000-0002-1829-7856